Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: The usefulness of sonazoid-enhanced harmonic sonography

Oncology

Volumn 75, Issue SUPPL. 1, 2008, Pages 99-105

  Xia, Yu ^a,b   Kudo, Masatoshi ^a   Minami, Yasunori ^a   Hatanaka, Kinuyo ^a   Ueshima, Kazuomi ^a   Chung, Hobyung ^a   Hagiwara, Satoru ^a   Inoue, Tatsuo ^a   Ishikawa, Emi ^a   Kitai, Satoshi ^a   Takahashi, Shunsuke ^a   Tatsumi, Chie ^a   Ueda, Taisuke ^a   Hayaishi, Sosuke ^a   Maekawa, Kiyoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Sonazoid; Sonazoid enhanced harmonic ultrasonography; Transcatheter arterial chemoembolization

Indexed keywords

EPIRUBICIN; FARMORBICIN; GELATIN SPONGE; GELPART; IODINATED POPPYSEED OIL; PERFLUBUTANE; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG RESPONSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SONAZOID ENHANCED HARMONIC SONOGRAPHY; TUMOR VASCULARIZATION; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; EPIRUBICIN; FEMALE; FERRIC COMPOUNDS; HUMANS; IODIZED OIL; IRON; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 58149100028     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173430     Document Type: Conference Paper

References (23)

1. Bruix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-524.
2. Yuen MF, Cheng CC, Lauder IJ, et al: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335.
3. Llovet JM, Real MI, Montana X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
4. Morimoto M, Shirato K, Sugimori K, et al: Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:65-69.
5. Numata K, Tanaka K, Kiba T, et al: Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR Am J Roentgenol 2001;176:1199-1205.
6. Bartolozzi C, Lencioni R, Caramella D, et al: Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994;191:123-128.
7. Okusaka T, Okada S, Ueno H, et al: Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology 2000;58:293-299.
8. Minami Y, Kudo M, Kawasaki T, et al: Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;180:703-708.
9. Ding H, Kudo M, Onda H, et al: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2001;176:661-666.
10. Watanabe R, Matsumura M, Munemasa T, et al: Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007;42:643-651.
11. Hatanaka K, Kudo M, Minami Y, et al: Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008;51:S61-S69.
12. Kudo M, Hatanaka K, Maekawa K: Sonazoid-enhanced ultrasound in the diagnosis and treatment of hepatic tumors. J Med Ultrasound 2008;16:130-139.
13. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
14. Takayasu K, Shima Y, Muramatsu Y, et al: Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987;163:345-351.
15. Uchida H, Ohishi H, Matsuo N, et al: Transcatheter hepatic segmental arterial embolization using Lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 1990;13:140-145.
16. Matsui O, Kadoya M, Yoshikawa J, et al: Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993;188:79-83.
17. Takayasu K, Arii S, Matsuo N, et al: Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 2000;175:699-704.
18. Saccheri S, Lovaria A, Sangiovanni A, et al: Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Interv Radiol 2002;13:995-999.
19. Ito K, Honjo K, Fujita T, et al: Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology. J Comput Assist Tomogr 1995;19:198-203.
20. Lencioni R, Caramella D, Bartolozzi C: Response of hepatocellular carcinoma to percutaneous ethanol injection: CT and MR evaluation. J Comput Assist Tomogr 1993;17:723-729.
21. Kubota K, Hisa N, Nishikawa T, et al: Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 2001;26:184-190.
22. Sontum PC, Ostensen J, Dyrstad K, et al: Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999;34:268-275.
23. Marelli C: Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection. Eur Radiol 1999;9(suppl 3):343-346.